• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    12/4/23 1:10:23 PM ET
    $ALK
    $ALT
    $ATHE
    $BETS
    Air Freight/Delivery Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALK alert in real time by email

    Shares of U Power Limited (NASDAQ:UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20 per unit.

    U Power shares dipped 54% to $0.7090 on Monday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) shares jumped 211.3% to $20.58 after the company announced the Phase 2 DAVIO 2 trial of EYP-1901 in wet AMD achieved all primary and secondary endpoints.
    • Hawaiian Holdings, Inc. (NASDAQ:HA) shares climbed 187% to $14.03 after Alaska Air Group, Inc. (NYSE:ALK) announced plans to acquire the company in a deal worth $1.9 billion.
    • Alterity Therapeutics Limited (NASDAQ:ATHE) shares climbed 156% to $4.25 after the company announced that ATHE434 new data in a Parkinson's disease primate model were presented at the Future of Parkinson's Disease Conference 2023.
    • SilverSun Technologies, Inc. (NASDAQ:SSNT) gained 142.7% to $8.91 after the company announced Jacobs Private Equity II and minority co-investors will invest $1 billion in the company.
    • Bit Brother Limited (NASDAQ:BETS) rose 86.3% to $0.0723 after surging 43% on Friday. Bit Brother said it purchased 3300 units of Antminer S19 miners, injecting powerful momentum into its Bitcoin mining operations.
    • Lucy Scientific Discovery Inc. (NASDAQ:LSDI) shares jumped 72.2% to $0.3530.
    • View, Inc. (NASDAQ:VIEW) gained 52.3% to $1.5701.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) rose 29.8% to $1.17.
    • Marpai, Inc. (NASDAQ:MRAI) jumped 28.3% to $1.9250.
    • CEL-SCI Corporation (NYSE:CVM) surged 25.6% to $2.6009. The UK'S National Institute for Health and Care Excellence selected CEL-SCI's Multikine as a potential new standard of care for head & neck cancer.
    • Cutera, Inc. (NASDAQ:CUTR) gained 25.3% to $2.33.
    • BIOLASE, Inc. (NASDAQ:BIOL) jumped 24.5% to $1.42.
    • Marpai, Inc. (NASDAQ:MRAI) rose 24% to $1.86. Marpai confirmed it has filed an appeal to NASDAQ Delisting Letter.
    • Beyond Meat, Inc. (NASDAQ:BYND) rose 23.6% to $9.36.
    • Altimmune, Inc. (NASDAQ:ALT) climbed 23% to $4.3850.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) gained 23% to $3.2950.
    • B. Riley Financial, Inc. (NASDAQ:RILY) rose 19.4% to $24.09. Bryant R. Riley reported sale of most of its stake in Arena Group to Arena.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) gained 16.8% to $6.10.
    • CleanSpark, Inc. (NASDAQ:CLSK) climbed 16.1% to $8.87amid a weekend increase in the price of Bitcoin.
    • Newegg Commerce, Inc. (NASDAQ:NEGG) gained 15.5% to $2.08.
    • Mercurity Fintech Holding Inc. (NYSE:MFH) jumped 15.4% to $1.12.
    • Carvana Co. (NYSE:CVNA) gained 15.3% to $40.56 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $25 to $40.
    • TeraWulf Inc. (NASDAQ:WULF) climbed 12.5% to $1.54 amid a weekend surge in the price of Bitcoin.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) gained 11.4% to $15.26 amid a weekend surge in the price of Bitcoin.
    • Spotify Technology S.A. (NYSE:SPOT) gained 8.6% to $196.07. Spotify CEO Daniel Ek announced significant organizational changes, including reducing the company's headcount by approximately 17%.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) shares rose 7.7% to $3.6530 after gaining 9% on Friday.
    • Science Applications International Corporation (NYSE:SAIC) gained 6.9% to $128.20 after the company reported third-quarter financial results and raised FY24 guidance above estimates.

    Losers

    • NexImmune, Inc. (NASDAQ:NEXI) fell 32.9% to $4.0619.
    • Meta Materials Inc. (NASDAQ:MMAT) declined 30.4% to $0.0765. Meta Materials announced a $6.0 million registered direct offering.
    • Clean Earth Acquisitions Corp. (NASDAQ:CLIN) fell 29.5% to $6.86.
    • Volato, Inc. (NYSE:SOAR) fell 28% to $10.44. Volato announced an agreement with Fly Alliance, to offer expanded aircraft options to its Gulfstream G280, HondaJet and Volato Insider Program Max customers.
    • Reborn Coffee, Inc. (NASDAQ:REBN) declined 24.4% to $0.5387.
    • Garden Stage Limited (NASDAQ:GSIW) fell 20.6% to $8.10 after surging 155% on Friday. Garden Stage announced pricing of initial public offering.
    • Dune Acquisition Corporation (NASDAQ:DUNE) fell 19% to $6.00.
    • Minim, Inc. (NASDAQ:MINM) fell 18.4% to $2.6015.
    • FOXO Technologies Inc. (NYSE:FOXO) shares fell 16.7% to $0.3404 after gaining over 22% on Friday. FOXO Technologies issued a business update on the planned commercial rollout of its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) dipped 16.6% to $0.5087 after jumping 39% on Friday. NLS Pharmaceutics launched an exclusive option agreement to develop and commercialize next generation dual orexin agonist platform of Aexon Labs.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) fell 16.2% to $1.96 following a report suggesting founder Richard Branson will not put any more money into the company.
    • Vivos Therapeutics, Inc. (NASDAQ:VVOS) fell 15.4% to $16.83 after dipping 19% on Friday. Vivos Therapeutics recently received FDA 510(k) clearance for treating severe obstructive sleep apnea in adults using the Vivos' removable CARE oral appliances.
    • Alaska Air Group, Inc. (NYSE:ALK) fell 15.1% to $33.72. Alaska Air Group announced plans to acquire Hawaiian Holdings in a deal worth $1.9 billion.
    • Neumora Therapeutics, Inc. (NASDAQ:NMRA) declined 14.8% to $10.49.
    • MINISO Group Holding Limited (NYSE:MNSO) dipped 11.6% to $21.42.
    • Cuentas Inc. (NASDAQ:CUEN) shares fell 8.1% to $1.3973 after gaining over 18% on Friday.
    • Sana Biotechnology, Inc. (NASDAQ:SANA) declined 8% to $3.72.
    • Nokia Oyj (NYSE:NOK) fell 7.6% to $3.2250.
    • Palantir Technologies Inc. (NYSE:PLTR) declined 7.2% to $18.82.
    • Kanzhun Limited (NASDAQ:BZ) fell 7% to $14.85.

     

    Now Read This: Bitcoin Tops $41,000; Terra Classic Emerges As Top Gainer

    Get the next $ALK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALK
    $ALT
    $ATHE
    $BETS

    CompanyDatePrice TargetRatingAnalyst
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Palantir Technologies Inc.
    $PLTR
    2/27/2026$150.00Buy
    Rosenblatt
    Palantir Technologies Inc.
    $PLTR
    2/27/2026$150.00Neutral → Buy
    UBS
    Spotify Technology S.A.
    $SPOT
    2/26/2026$586.00Neutral → Buy
    Arete
    Palantir Technologies Inc.
    $PLTR
    2/18/2026$195.00Neutral → Outperform
    Mizuho
    Neumora Therapeutics Inc.
    $NMRA
    2/17/2026Mkt Perform → Outperform
    William Blair
    Spotify Technology S.A.
    $SPOT
    2/11/2026$875.00 → $420.00Buy → Hold
    Pivotal Research Group
    Palantir Technologies Inc.
    $PLTR
    2/10/2026$180.00Neutral → Buy
    Daiwa Securities
    More analyst ratings

    $ALK
    $ALT
    $ATHE
    $BETS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:05:04 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Durso Jerome Benedict bought $70,790 worth of shares (20,000 units at $3.54), increasing direct ownership by 160% to 32,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:00:05 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP,-Air Force & Comb Commands Difronzo Vincent P. was granted 2,517 shares and covered exercise/tax liability with 1,064 shares, increasing direct ownership by 34% to 5,729 units (SEC Form 4)

    4 - Science Applications International Corp (0001571123) (Issuer)

    3/6/26 4:57:49 PM ET
    $SAIC
    EDP Services
    Technology

    $ALK
    $ALT
    $ATHE
    $BETS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Marpai Secures Access to Network Creating Major Growth Catalyst for MarpaiRx Representing Up to 1.5 million Covered Lives

    Marketing Agreement Establishes Powerful National Distribution Channel and Expands Marpai's Revenue Growth OpportunityTAMPA, Fla., March 9, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management (PBM) services, today announced the execution of a transformational marketing agreement dramatically expanding the national reach of its high-growth pharmacy benefit management division, providing access to a network representing up to 1.5 million covered employees for MarpaiRx.The agreement creates a powerful new distribution channel for MarpaiRx's pharmacy benefit sol

    3/9/26 8:08:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit

    MELBOURNE, Australia and SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced  that David Stamler, M.D., Chief Executive Officer of Alterity, will participate in the Bell Potter Healthcare Horizons Summit taking place 12-13 March 2026 in Sorrento, Australia. At the conference, Dr. Stamler will participate in a fireside chat entitled, "Optimising Late-stage Clinical Trials to Increase the Odds," and will also host 1-on-1 investor meetings. About Alterity Therapeutics Limited  Alterity Therap

    3/9/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    KANZHUN LIMITED to Report Fourth Quarter and FY2025 Results on March 18, 2026

    BEIJING, March 06, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HKEX: 2076)), a leading online recruitment platform in China, today announced that it will report its unaudited consolidated results for the fourth quarter and full year ended December 31, 2025, before the U.S. market opens on Wednesday, March 18, 2026. The Company will host a conference call on Wednesday, March 18, 2026 at 8:00PM Beijing Time (8:00AM U.S. Eastern Time) to discuss the results. Participants are required to pre-register for the conference call at:https://register-conf.media-server.com/register/BI4c5b047965fc423ea1aa4f7ec2d0e319 Upon registration, participants will rece

    3/6/26 9:00:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    $ALK
    $ALT
    $ATHE
    $BETS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Weaver Gregory L bought $17,700 worth of shares (5,000 units at $3.54), increasing direct ownership by 22% to 28,078 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:05:04 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Durso Jerome Benedict bought $70,790 worth of shares (20,000 units at $3.54), increasing direct ownership by 160% to 32,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    3/9/26 7:00:05 AM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Bucella Michael C. bought $50,038 worth of shares (3,171 units at $15.78), increasing direct ownership by 1% to 270,129 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/4/26 5:34:43 PM ET
    $WULF
    EDP Services
    Technology

    $ALK
    $ALT
    $ATHE
    $BETS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MARA Holdings Inc. downgraded by H.C. Wainwright

    H.C. Wainwright downgraded MARA Holdings Inc. from Buy to Neutral

    2/27/26 11:05:23 AM ET
    $MARA
    EDP Services
    Technology

    Rosenblatt initiated coverage on Palantir Technologies with a new price target

    Rosenblatt initiated coverage of Palantir Technologies with a rating of Buy and set a new price target of $150.00

    2/27/26 8:31:30 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Palantir Technologies upgraded by UBS with a new price target

    UBS upgraded Palantir Technologies from Neutral to Buy and set a new price target of $150.00

    2/27/26 8:22:27 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $ALK
    $ALT
    $ATHE
    $BETS
    SEC Filings

    View All

    SEC Form 6-K filed by Alterity Therapeutics Limited

    6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer)

    3/9/26 8:00:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by KANZHUN LIMITED

    6-K - Kanzhun Ltd (0001842827) (Filer)

    3/9/26 6:02:22 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    Beyond Meat Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - BEYOND MEAT, INC. (0001655210) (Filer)

    3/6/26 4:32:50 PM ET
    $BYND
    Packaged Foods
    Consumer Staples

    $ALK
    $ALT
    $ATHE
    $BETS
    Financials

    Live finance-specific insights

    View All

    KANZHUN LIMITED to Report Fourth Quarter and FY2025 Results on March 18, 2026

    BEIJING, March 06, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HKEX: 2076)), a leading online recruitment platform in China, today announced that it will report its unaudited consolidated results for the fourth quarter and full year ended December 31, 2025, before the U.S. market opens on Wednesday, March 18, 2026. The Company will host a conference call on Wednesday, March 18, 2026 at 8:00PM Beijing Time (8:00AM U.S. Eastern Time) to discuss the results. Participants are required to pre-register for the conference call at:https://register-conf.media-server.com/register/BI4c5b047965fc423ea1aa4f7ec2d0e319 Upon registration, participants will rece

    3/6/26 9:00:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    SAIC Schedules Fourth Quarter Fiscal Year 2026 Earnings Conference Call for March 16 at 10 A.M. EDT

    RESTON, Va., March 03, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ:SAIC) is scheduled to issue its fourth quarter fiscal year 2026 results before market open on Monday, March 16, 2026. SAIC executive management will discuss operational and financial results in a conference call beginning at 10:00 a.m. EDT, following the issuance of the company's earnings press release.  The conference call will be webcast simultaneously to the public through a link on the Investor Relations section of the SAIC website. The company will only provide webcast access, "dial-in" access will not be available. A supplemental presentation will be available to the public through links

    3/3/26 8:30:00 AM ET
    $SAIC
    EDP Services
    Technology

    MARA Announces Fourth Quarter and Fiscal Year 2025 Results

    Miami, FL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a leading energy and digital infrastructure company, today announced its preliminary, unaudited fourth quarter and fiscal year 2025 financial results in a letter to shareholders. Investors are invited to access the fourth quarter 2025 shareholder letter at MARA's website at ir.mara.com. A copy of the letter will also be furnished to the Securities and Exchange Commission on a Form 8-K. MARA will hold a webcast and conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) today to discuss these financial results. To register to participate in the conference call, please use

    2/26/26 4:20:00 PM ET
    $MARA
    EDP Services
    Technology

    $ALK
    $ALT
    $ATHE
    $BETS
    Leadership Updates

    Live Leadership Updates

    View All

    Reborn Coffee Appoints Jung Jae Lim as Co-Chief Executive Officer to Strengthen Supply Chain Execution and Drive New Growth

    Board-Approved Leadership Appointment Adds Deep Logistics and Operational Expertise to Accelerate Enterprise Partnerships and Platform Scale BREA, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Reborn Coffee, Inc. (NASDAQ:REBN) (the "Company") today announced that its Board of Directors, through duly approved and executed Board minutes, has appointed Jung Jae Lim as Co-Chief Executive Officer of Reborn Coffee, Inc., effective March 3, 2026. Mr. Lim brings more than 20 years of leadership experience in logistics and supply chain management, with a background overseeing large-scale operations, multi-node distribution networks, and end-to-end supply chain execution across multiple sectors.

    3/6/26 8:31:00 AM ET
    $REBN
    Restaurants
    Consumer Discretionary

    Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor

    MELBOURNE, Australia and SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that Daniel O. Claassen, M.D., M.S., was appointed Chief Medical Advisor and will begin his role in March 2026. As a tenured professor, Dr. Claassen will also retain his academic appointment at Vanderbilt University Medical Center. Dr. Claassen is a board-certified neurologist and internationally recognized expert in neurodegenerative diseases, with more than two decades of clinical and translational research in mov

    3/4/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sharon AI Appoints Mr. Benjamin Adams to Board of Directors

    SharonAI Holdings Inc. ("Sharon AI"), a leading Australian neocloud (NASDAQ:SHAZ), announced on February 24, 2026, that highly experienced global technology executive, Mr. Benjamin Adams, joined the Sharon AI Holdings Inc. board of directors on February 22, 2026. Mr. Adams is a global business and technology leader with deep and broad expertise across financial, technology and regulatory law, mergers & acquisitions, corporate securities reporting, intellectual property and real estate. "I am honoured to join the board at such a pivotal and exciting time. I look forward to leveraging my experience to help Sharon AI shape its strategic goals and expand its impact in the coming years," sai

    3/3/26 7:30:00 AM ET
    $MSFT
    $NOK
    $PYPL
    Computer Software: Prepackaged Software
    Technology
    Radio And Television Broadcasting And Communications Equipment
    Diversified Commercial Services

    $ALK
    $ALT
    $ATHE
    $BETS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Newegg Commerce Inc.

    SC 13D/A - Newegg Commerce, Inc. (0001474627) (Subject)

    12/17/24 4:37:51 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care